About this trial
To evaluate and compare the effectiveness of the Pericapsular Nerve Group (PENG) block alone versus the PENG block combined with the Lateral Femoral Cutaneous Nerve (LFCN) block in providing adequate analgesia for patient positioning during spinal anesthesia in individuals undergoing surgery for hip fracture.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-70 years.
ASA I-II.
Confirmed primary unilateral hip fracture.
Scheduled for surgery under spinal anesthesia.
Disqualifiers
Allergy to local anesthetics.
Coagulopathy or on anticoagulant therapy.
Infection at injection site.
Pre-existing neurological deficits in the lower limbs.
Trial design
Parallel
Treatments tested in this trial
PENG Block
Procedure/SurgeryPericapsular Nerve Group Block
LCFN block
Procedure/SurgeryLateral Femoral Cutaneous Nerve block
bupivacaine 0.25%.
Drug0.25% of Bupivacaine (Bupivacaine 0.5% is added to Lidocaine 2% in the same volume)
Xylocaine 2 %
Druglocal infilteration at the insertion site
Treatment groups
Trial outcomes
Primary outcomes
To compare the time taken to achieve optimal positioning for spinal anesthesia in both groups
time taken in seconds for positioning for spinal anesthesia 15 minutes post- block
Secondary outcomes
To assess Numerical Rating Pain Score in both groups at 0,5,10 and 15 minutes post block
It refers to the common method used in healthcare where patients rate their pain on a scale from 0 to 10 (0 = No pain 10 = Worst pain imaginable).
To assess patient satisfaction and comfort during positioning using Likert scale
5-Point scale (1=strongly disagree and 5=strongly agree). The participants measure it 15 minutes post- block during positioning for spinal anesthesia
To monitor mean arterial blood pressure
Comparing mean arterial blood pressure between the 2 groups by millimeter of mercury (mmhg) at 0,5,10 and 15 minutes post-block.
To monitor heart rate
Comparing the heart rate ( by beats per minute) in the 2 groups at 0,5,10 and 15 minutes post-block.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.